dual agonist tirzepatide is a first-in-class targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances 1 and GIP therapy Compounded Tirzepatide for Women |
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























